3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Neoplasms
2
Brain Neoplasms
2
Sarcoma
1
Pituitary Neoplasms
1
Osteosarcoma
1
Oligodendroglioma
1
Neurotoxicity Syndromes
1
Neurofibromatosis 1
1
Multiple Myeloma
1
Meningioma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Lung Neoplasms
1
Hodgkin Disease
1
Glioma
1
Fatigue
1
Cytokine Release Syndrome
1
Astrocytoma
1
Interventions
Magnetic Resonance Spectroscopy
6
Yoga
2
Vincristine
2
Temozolomide
2
Surgical Procedures, Operative
2
Radiotherapy
2
Magnetic Resonance Imaging
2
Gadolinium DTPA
2
Carboplatin
2
Biopsy
2
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
2
gallium Ga 68 dotatate
1
gadobutrol
1
gadobenic acid
1
fluorodopa F 18
1
alovudine
1
Surveys and Questionnaires
1
Polymerase Chain Reaction
1
Neuropsychological Tests
1
Mind-Body Therapies
1
Methotrexate
1
Meditation
1
Heart Rate
1
Gelclair
1
Etoposide
1
Etanidazole
1
Equipment and Supplies
1
Early Intervention, Educational
1
Diffusion Tensor Imaging
1
DNA Methylation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Oligodendroglioma
×
Neuropsychological Tests
×
Clear all
NCT02903784
2020-09-02
BNL
University Hospital, Montpellier
Phase NA
Completed
63 enrolled